ALBIREO PHARMA, INC. Annual Operating Income (Loss) in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Albireo Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2021.
  • Albireo Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$34.7M, a 11.5% increase year-over-year.
  • Albireo Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$123M, a 7.86% increase year-over-year.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2021 was -$123M, a 28.3% decline from 2020.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2020 was -$96.3M, a 57.5% decline from 2019.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2019 was -$61.1M, a 61.3% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$123M -$27.2M -28.3% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-01
2020 -$96.3M -$35.2M -57.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$61.1M -$23.2M -61.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$37.9M -$13.3M -54.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 -$24.6M -$12.3M -99.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$12.3M -$7.57M -160% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-27
2015 -$4.73M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.